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ABSTRACT We reacted a fluorescent probe, N-methyl-2-anilino-6-naphthalenesulfonyl chloride (MNS-CI), with a specific
lysine residue of porcine cardiac myosin located in the S-2 region of myosin. We performed fluorescence resonance energy
transfer (FRET) spectroscopy measurements between this site and three loci (Cysl 09, Cysl 25, and Cysl 54) located within
different myosin light-chain 2s (LC2) bound to the myosin "head." We used LC2s from rabbit skeletal muscle myosin (Cysl 25),
chicken gizzard smooth muscle myosin (Cysl 09), or a genetically engineered mutant of chicken skeletal muscle myosin
(Cysl 54). The atomic coordinates of these LC2 loci can be closely approximated, and the FRET measurements were used to
determine the position of the MNS-labeled lysine with respect to the myosin head. The C-terminus of myosin subfragment-1
determined by Rayment et al. ends abruptly after a sharp turn of its predominantly a-helical structure. We have
constructed a model based on our FRET distance data combined with the known structure of chicken skeletal muscle myosin
subfragment-1. This model suggests that the loci that bracket the head-rod junction will be useful for evaluating dynamic
changes in this region.
INTRODUCTION
The myosin head has two distinct domains, a globular,
active motor domain and a narrower neck region called the
light-chain domain. A model of force generation (Rayment
et al., 1993a; Spudich, 1994) proposes that the binding and
hydrolysis of ATP results in the head being activated in a
"6pre-powerstroke" conformation. The motor domain then
undergoes a conformational change when it binds strongly
to actin. The light-chain domain then swings through an
angle of approximately 450, corresponding to a movement
of 5-10 ,tm at the head-rod junction. Thus, this model
proposes that the light-chain domain acts as a lever for the
motor domain, amplifying the force-generating conforma-
tional change that occurs in the motor domain. Recent spin
resonance spectroscopic data, from a probe bound to LC2,
support the hypothesis that the light-chain domain is disor-
dered during the entire contractile cycle, consistent with its
swinging through large angles during contraction (Hambly
et al., 1992).
Striated muscle is regulated by the thin filament-based
troponin-tropomyosin system, whereas in smooth and non-
muscle tissue, force generation is regulated via phosphory-
lation of the myosin regulatory light chain (LC2) (Kendrick-
Jones and Scholey, 1981). In cardiac (Malhotra et al., 1979)
and skeletal muscle (Metzger and Moss, 1992; Sweeney et
al., 1993), additional modulatory mechanisms may exist, for
example, modulation by LC2. The mechanism by which
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LC2 regulates or modulates the myosin ATPase activity is
not well understood.
LC2 has a Mr of -20 kDa and is a member of the
Ca2+-binding regulatory protein superfamily. These pro-
teins have a dumbbell-like shape and are characterized by
strong structural homology to calmodulin (Meador et al.,
1992) and troponin-C (Collins, 1991). In the crystal struc-
ture of S-1, the LC2 (Rayment et al., 1993b; Xie et al.,
1994) wraps around and stabilizes the single a-helix of the
MHC. The a-helix of the myosin heavy chain (MHC) in the
light-chain binding domain undergoes a sharp bend of 40-
90° at the center of the LC2-binding site. A highly con-
served (invariant) proline (Pro840) is thought to demarcate
the head-rod junction (Rimm et al., 1989). The proximity
between LC2 and the putative head-rod junction suggests
that these two structures may interact during force produc-
tion (Miller and Reisler, 1985).
An experimental means of measuring movements be-
tween the LC domain (e.g., LC2) and the S-2 moiety would
be valuable for testing molecular models. Fluorescence
spectroscopy has a proven record for measuring distances in
contractile proteins and would be appropriate in this con-
text, provided that loci are available that can be specifically
labeled. Hiratsuka and Uchida (1977) found that the fluo-
rescent probe N-methyl-2-anilino-6-naphthalenesulfonyl
chloride (MNS-C1) selectively reacts with lysyl residues
located close to the head-rod junction of porcine cardiac
myosin. In the absence of divalent metal ions, porcine
cardiac myosin contains two distinct Lys residues that react
with MNS-Cl. However, in the presence of Ca2+, a single
different Lys residue reacts with the MNS-Cl probe (Hirat-
suka and Uchida, 1980). The fluorophore is believed to be
close to the head-rod junction, for which there is no known
sequence. Its position has not been identified more specif-
ically than within a 6600-Da chymotryptic SL-S2 linker
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peptide of porcine cardiac myosin (Hiratsuka and Uchida,
1981). Hiratsuka (1981) found that the MNS probe was
sensitive to actin binding.
In this study we have exchanged LC2, labeled with the
fluorescent probe 5-iodoacetamidofluorescein (5-IAF), onto
MNS-labeled porcine cardiac myosin. Fluorescence reso-
nance energy transfer (FRET) was then performed between
the donor-labeled site on the S-2 region of the MHC and the
acceptor-labeled site on LC2. Thus, using the Forster theory
of FRET, it is possible to establish the proximity of LC2 to
the MNS site on S-2, thus bracketing the head-rod junction.
MATERIALS AND METHODS
Proteins and chemical reagents
ATP, papain, a-chymotrypsin, bovine thrombin, and proteinase-K were
purchased from the Sigma Chemical Co. Cardiac myosin was prepared
from the left ventricles of freshly slaughtered pig as described by
Murakami et al. (1976), except for the addition of further protease inhib-
itors leupeptin, chymostatin, phenylmethylsulfonyl fluoride, and TLCK
(10 mg/liter) to the washing and extraction buffers. Smooth muscle LC2
was prepared from the gizzards of freshly slaughtered chickens by the
method of Grand and Perry (1983). Rabbit skeletal muscle LC2 was
prepared using the method of Holt and Lowey (1975). Rabbit skeletal
muscle actin was prepared from acetone powder by the method of Spudich
and Watt (1971).
A mutant LC2 containing one Cys residue at position 154 (C125R) was
also used. A chicken fast skeletal LC2 cDNA clone (expression vector:
pLcIIFXMLC) (Reinach et al., 1986) was mutated by using oligonucleo-
tide-primed site-directed mutagenesis as described previously (Boey et al.,
1994). The endogenous Cysl25 was substituted with an Arg (a conserva-
tive substitution found in chicken gizzard LC2 and chosen because it is
likely to produce a functional LC2). The base change in the LC2 gene was
confirmed by sequencing. The plasmid expressed a fusion protein consist-
ing of a 31-residue peptide linked to the N-terminus of LC2 by a thrombin
cleavage site. Removal of this fusion peptide was performed as described
by Reinach et al. (1986) with modifications. C125R fusion peptide protein
was dialyzed into thrombin digestion buffer (100 mM NaCl, 0.5 mM
dithiothreitol (DTT), 40 mM Tris, pH 8.0). Bovine thrombin was sus-
pended at 100 National Institutes of Health Units/ml, and digestion was
carried out at 2 mg/ml protein, at 23°C in the presence of 1:40 v/v thrombin
for 3 h. After cleavage, C125R was purified by Q-Sepharose (Pharmacia)
anion exchange chromatography in 2 M urea, 50 mM Tris (pH 8.0), 0.5
mM DTT.
Labeling of MHC
All of the labeling steps were performed at 4°C unless otherwise specified.
MNS-Cl and 5-IAF were purchased from Molecular Probes. A 12-fold
molar excess of MNS-Cl was added to myosin (5 mg/ml), as described by
Hiratsuka and Uchida (1977), in the presence of 2 mM Ca2 . The reaction
was terminated by the addition of 10 volumes of cold water and centrifuged
at 6500 X g for 10 min. Myosin was redissolved in 0.5 M KCl, 2 mM
CaCl2, 40 mM Na-borate (pH 8.0) and dialyzed exhaustively. The extent of
labeling was determined by the absorption difference between labeled and
unlabeled myosin at 327 nm, using an extinction coefficient of 2.0 x 104
M-l cm-' (Hiratsuka and Uchida, 1977). The myosin concentration was
established from its absorbance at 280 nm by using an extinction coeffi-
cient of 0.56 (Chock and Eisenberg, 1979). Labeling ratios were in the
range of 0.59-1.0. The labeled myosin was designated as MNS-myosin.
Labeling of gizzard LC2 at CyslO9
Lyophilized chicken gizzard LC2 was incubated in 6 M guanidine hydro-
chloride (GuHCl), 10mM DTT, and 100 mM Tris (pH 8.0) for 2 h at 22°C.
This was then dialyzed for 24 h at 4°C in 100 mM NaCl, 2 mM EDTA, and
20 mM imidazole and centrifuged at 130,000 X g for 30 min to remove
denatured protein. Protein concentration was estimated by measuring the
UV absorbance at 280 nm, using an extinction coefficient of 0.60 (Holt and
Lowey, 1975). A 5 M excess of 5-IAF was added over the LC2 concen-
tration and incubated for 40 min. The reaction was terminated by the
addition of 100-fold excess of DTT over 5-IAF. Excess probe was removed
by chromatography on Sephadex G-25 (Pharmacia) equilibrated with 0.2
mM DTT, 0.2 mM EDTA, and 0.15 M Na-phosphate (pH 7.0). The extent
of labeling at CyslO9 was determined at 495 nm, using an extinction
coefficient of 5.47 X 104 M-l cm-' (Marsh and Lowey, 1980). As 5-IAF
has a significant absorption at 280 nm, the concentration of LC2 was
determined by using a standard Coomassie assay, (Bradford, 1976). We
obtained labeling ratios between 0.79 and 1.08.
Labeling of Cys125
Cys 125 of rabbit skeletal muscle LC2 was modified specifically with
5-IAF, using the method described by Katoh and Lowey (1989). LC2 (1-2
mg/ml) was reduced for 2 h at 22°C in 6 M GuHCI, 10 mM DTT, and 0.1
M Tris (pH 8.0) and dialyzed exhaustively against 0.1 M NaCl, 2 mM
EDTA, 20 mM imidazole (pH 7.0) before labeling with 5 M excess
fluorophore for 45 min at 4°C. The sample was then immediately passed
through a Sephadex G-25 column (equilibrated in 0.2 mM DTT, 0.2 mM
EDTA, 0.15 M Na-P04, pH 7.0) to remove the excess probe. To remove
unlabeled and double-labeled LC2, it was further purified by passage
through a Q-Sepharose column equilibrated in the same buffer. Unlabeled
LC2 eluted with the void volume, and labeled LC2 eluted with a linear
gradient to 0.4 M Na-PO4. The first eluted peak contained single-labeled
LC2 and the second double-labeled LC2. Fractions containing single-
labeled LC2 were pooled for exchange onto myosin.
Labeling of Cysl54
Mutant chicken fast skeletal myosin LC2 (Cl25R) containing one Cys at
position 154 was reduced and labeled, using the same conditions and
procedures described for rabbit skeletal myosin LC2, except that 2 M urea
was included in the labeling buffer.
Exchange of labeled LC2 onto MNS-labeled
myosin
MNS-myosin (2 mg/ml) was incubated for 15 min at 37°C in buffer free of
Ca2+ or Mg2+ (0.5 M NaCl, 2 mM EDTA, 5 mM ATP, and 40 mM Tris,
pH 8.0) to remove native LC2 (Wikman-Coffelt et al., 1979). The reaction
was terminated by precipitating myosin in 10 volumes of ice cold water
and centrifuged at 40,000 X g for 15 min at 4°C. Myosin was redissolved
in 0.5 M NaCl, 5 mM MgCl2, and 50 mM Tris (pH 8.0). A 3 M excess of
labeled LC2 was added to MNS-myosin, and the mixture was incubated for
12 h at 4°C. Unexchanged LC2 was removed by the addition of 10 volumes
of ice-cold water; centrifuged at 40,000 X g for 15 min; dissolved in 0.5
M KCl, 2 mM MgCl2, 40 mM Na-borate (pH 8.0); and repeated. Denatured
proteins were removed by centrifugation at 130,000 X g for 60 min. The
amount of LC2 exchanged onto myosin was quantified by UV/Vis spec-
troscopy and Coomassie protein assays, assuming that the concentration of
5-IAF (determined from its absorbance peak at 495) was equivalent to the
amount of acceptor-labeled LC2 exchanged onto the MHC. MHC:LC2
ratios of 0.72-1.0 were achieved. The hybrid myosins are referred to as
MNS-109, MNS-125, and MNS-154.
Myosin ATPase activities at low ionic strength (33 mM KCl) in the
presence and absence of a 2 M excess of F-actin were measured by using
a pH stat as described elsewhere (dos Remedios and Barden, 1977). All
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myosin ATPase rates were within ± 10% of the control (unlabeled myosin
with native LC2s) activities (data not shown).
Fluorescence measurements
The fluorescence spectra were recorded with an SLM 8000 photon-count-
ing spectrofluorimeter operated in ratio mode with a rhodamine standard as
described previously (Barden and dos Remedios, 1984). Samples were
placed in cuvettes, and the temperature was regulated at 20°C and con-
stantly stirred. The protein concentration in all samples was adjusted to
approximately 1 mg/ml in 0.5 M KCl, 2mM MgCI2, and 40 mM Na-borate
(pH 8.0). Excitation wavelength for all samples was at 330 nm, and the
emission spectra were recorded in the range of 380-480 nm.
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FRET analysis
The efficiency of FRET between a donor and an acceptor probe was
calculated according to the Forster (1965) equation:
E = R6l(R6 + R6) (1)
where
R = 9.78 X 103(Jn-4k2QD)16, (2)
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where E is the efficiency of resonance energy transfer; Ro is the Forster
distance between donor and acceptor probe at which the efficiency is 50%;
R is the distance separating the donor and acceptor probes; k2 is the dipolar
orientation factor and is assumed to be equal to 2/3 (see dos Remedios,
1977; dos Remedios and Moens, 1995, for a detailed discussion of this
assumption); n is the refractive index of the medium; QD is the quantum
yield of the donor; and J is the overlap integral between the emission
spectrum of the donor [FD(I)] and the absorption spectrum of the acceptor
[eA(l)] in M-' cm-'. J is defined as
J= JFD(l)eA(1)14dl4/JFD(l)dl. (3)
E is calculated from the equation
E = 1-(Fda/Fd), (4)
where Fda and Fd are the fluorescence intensities of the donor in the
presence and absence of acceptor, respectively.
RESULTS
Labeling a specific lysine in S-2
In the absence of free Ca21 we confirmed the observations
of Hiratsuka and Uchida (1977), who reported a 2:1 labeling
stoichiometry of MNS:myosin, i.e., one label for each of the
two strands of the porcine cardiac MHC. However, when
this myosin was labeled in the presence of free Ca2 , the
MNS:myosin ratio was -1.0. We confirmed the require-
ment for Ca2+ to achieve a stoichiometry of one MNS label
per myosin molecule. In a series of six separate experi-
ments, the labeling ratios varied in the range 0.59-1.0
moles of MNS per MHC. Thus, Hiratsuka's procedure
achieves one mole of label per myosin, i.e., only one label
for every two MHCs in the presence of Ca2+.
Comparison of the near-UV spectra for single (curve b in
Fig. 1) and double (curve a in Fig. 1) MNS-labeled myosins
Wavelength (nm)
FIGURE 1 Near-UV absorption spectra of porcine cardiac myosin la-
beled with a 12-molar excess of MNS-Cl in the absence (curve a) and
presence (curve b) of 2 mM Ca2+. Note the blue shift of the spectrum
2+obtained when myosin is labeled in the presence of Ca
reveals a blue shift of the absorbance of the single-labeled
preparations (peak occurs at 327 nm). This suggests that the
solvent environment of this label is more hydrophobic than
for the double-labeled myosin, where the peak occurs at
335-340 nm.
In the presence of Ca2+ the MNS probe reported by
Hiratsuka was located in the S-2 region of myosin (Hirat-
suka and Uchida, 1981). We confirmed this by producing
standard HMM and S-1 fragments of myosin by using
chymotrypsin and papain, respectively. The fluorescence
emission spectra of MNS-labeled HMM and S-1 are illus-
trated in Fig. 2. This comparison suggests that essentially all
of the fluorescence resides in HMM.
Preliminary experiments with myosins from other species
produced different results. When we labeled bovine cardiac
myosin with a 12-fold excess of MNS-Cl, the myosin:label
stoichiometry was in excess of 2:1. A similar result was
obtained by using myosin isolated from rabbit skeletal mus-
cle. These observations suggests that pig heart myosin may
have either a unique primary structure or a unique confor-
mation due to its interaction with other ligands (Hiratsuka,
personal communication).
Energy transfer between MNS-myosin and LC2
5-IAF-labeled at CyslO9, Cysl25, or Cysl54
Fig. 3 illustrates the corrected fluorescence spectra of my-
osin labeled with a single MNS probe (MNS-myosin) in the
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and acceptor probes were determined by using three sepa-
rately prepared samples of MNS-myosin exchanged with
5-IAF-labeled LC2 (Table 1). The measurements yielded an
average transfer efficiency of 0.62.
Precisely equivalent experiments were performed by us-
ing the 5-IAF acceptor bound to rabbit skeletal myosin LC2
(Cysl25) and to a chicken skeletal muscle myosin mutant
LC2 (Cys154). The corresponding FRET efficiencies are
summarized in Table 1.
The distances between the donor and acceptor probes
were calculated with Eq. 1. The parameters used in calcu-
lating the Ro are summarized in Table 2, where J was
calculated from the absorption-emission spectra of the
MNS-labeled myosin. Ro for the probe pair MNS-Cl (do-
nor)/5-IAF (acceptor) was calculated to be 2.68 nm. The
distance values (R) were then calculated from the observed
460 480 FRET efficiencies and are summarized in Table 1. The
mean distances between the MNS donor and 5-IAF accep-
iyosin digested to
tors were 2.48 nm (CyslO9), 2.31 nm (Cysl25), and 2.56
ions were 0.5 mM nm (Cys 154).
rated in multiscan
n monochromator
vas 330 nm. The DISCUSSION
Structure of the S-1-S-2 portion of myosin
The structure of the a-carbon backbone of S-1 and its
urve) of 5-IAF associated myosin light chains is now well defined; this is
he curves have shown in Fig. 4 a. The truncated myosin heavy chain
Ld for the ratio illustrated in Fig. 4 b has approximately the same orienta-
;in has a peak tion as the S-I shown in Fig. 4 a. It commences at Val700
iple, the FRET and is traced to its termination at Lys843. Thus, residues 1
veen the donor to 700 are not visualized in this figure, some of which
overlaps this region. The important features of the heavy-
chain structure are the extended a-helix (green), which
begins in the so-called motor domain and extends into the
"light-chain" domain as a nearly linear structure.
First LC1 and then LC2 are "wrapped" around this helix.
The sequence of the cognate peptide that binds to Ca2+_
binding regulatory proteins exhibits a characteristic motif:
the IQ motif (Xie et al., 1994). Such motifs occur within the
MHC sequences that bind both LCs, although the motif for
LC2 is significantly altered. The target sequences of calm-
460 480
FIGURE 3 Corrected fluorescence emission spectra of MNS-myosin
(solid line) and MNS-5-IAF-CyslO9 (broken line). The acquisition time
was 1 s, and excitation and emission monochromator slits were both set at
4 nm. The excitation wavelength was 330 nm, and fluorescence quench
was monitored at 438 nm. The FRET efficiency of this sample was 0.58.
TABLE I Summary of the FRET data
Location of acceptor
probe on LC2 A/D Corrected E R 2/3 (nm) Mean R (nm)
CyslO9 0.94 0.58 2.54 2.48
0.81 0.61 2.49
1.05 0.66 2.40
Cysl25 0.72 0.71 2.31 2.31
Cysl54 1.00 0.50 2.68 2.56
1.06 0.63 2.45
In all experiments the donor (D) was located on a Lys of myosin S-2. E is
the efficiency of energy transfer calculated from Eq. 4; R is the distance
between the donor and acceptor (A) probes calculated using Eq. 1; Ro =
2.68 nm. We have assumed that the probes were able to freely precess and
therefore have an orientation factor (K2) value of 2/3.
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TABLE 2 A summary of the parameters used in calculating
the Forster distance (RO)
Donor Acceptor J n K2 QD Ro (nm)
MNS-Cl 5-IAF 1.97 x 10-'4 1.33 0.67 0.10 2.68
QD was obtained from Hiratsuka and Uchida (1980).
odulin-binding peptides and the binding site for the alkali
light chains of myosin all form single straight a-helices.
However, the binding of LC2 to the MHC differs from this
in that there has been an "insertion" of the central three
residues into the IQ motif (829-831). This insertion causes
it to undergo a 40-90° bend, depending on the myosin
isotype (Rayment et al., 1993b; Xie et al., 1994).
The heavy chain continues for 12 more residues beyond
the bend within LC2. These form three turns of an a-helix
before terminating at Lys843. This C-terminal a-helix now
points in a direction nearly at right angles to the axis of the
head. When Rayment et al. (1993a) fitted the F-actin-S-1
model into the context of the myofibril, this C-terminal
helix pointed toward the M-line and represented an appro-
priate mechanical arrangement for S-1 to apply tension to
the rod portion of the myosin. Thus, the model of Rayment
et al. predicts that the S-2 segment continues in the direction
indicated in Fig. 4. The flexible hinge of the MHC at
Pro840, believed to constitute the head-rod junction (Rimm
et al., 1989), is four residues beyond the C-terminus of the
S-I crystal structure.
A specific labeling site on myosin
The generation of S-I by proteolytic digestion produces
several peptides that lie between S-I and S-2. One of these
is a 6.6-kDa "linker" peptide that Hiratsuka identified as
containing the MNS-sensitive lysine. Our experiments con-
firmed observations by Hiratsuka and his colleagues (Hirat-
suka, 1981; Hiratsuka and Uchida, 1977, 1980), namely that
1 mole of the MNS label is incorporated into each mole of
porcine cardiac myosin when the reaction is carried out in
the presence of excess Ca2 . In the absence of added Ca2 ,
two moles of MNS are incorporated per myosin, resulting in
characteristically different UV absorbance and fluorescence
emission spectra. Hiratsuka concluded that different loci are
labeled in the presence and absence of Ca2 . Our results
demonstrate that the 1: 1 labeling in the presence of Ca2+ is
not a general property of striated myosins because a >> 1: 1
ratio was achieved by using bovine cardiac or rabbit skeletal
muscle myosins.
The MNS label was localized to the S-2 region of the
MHC, and our data show that essentially all of the fluores-
cence intensity is associated with HMM rather than S-1.
This is consistent with Hiratsuka's observation (Hiratsuka,
1981) that the MNS-labeled lysine is located in the 6.6-kDa
S-2 fragment.
The problem of one donor and two acceptors
Each mole of LC2 may exchange at two possible sites on
myosin. This exchange may be random or may involve
positive or negative cooperativity. Wagner and Weeds
(1977) reported that LC2 does not exchange equally onto
both heads and concluded that the exchange exhibited neg-
ative cooperativity. The maximum level of exchange in our
experiments was about 1 mole of label per mole of myosin,
which is consistent with the conclusion of these authors.
Thus it is likely that only a very small proportion of myosin
molecules will contain two acceptors.
In the event that myosin does contain two acceptors, the
distance calculations can be modified to take this circum-
stance into account. The equation for calculating distances
in multiacceptor systems is
En(R6/R6) = (E1 -1)-', (5)
where n is the number of acceptors. For two equidistant
acceptors the equation for the distance between the probes
reduces to
R = RO(2)1/6(E1 - 1)1/6. (6)
For one donor and one acceptor, the calculated distances
(R) were 2.48, 2.31, and 2.56 nm for the CyslO9, Cysl25,
and Cys154, respectively. If we assume that all of our
donors are equidistant from two acceptors then, using Eq. 6,
the distances increased to 2.78, 2.59, and 2.87 nm, respec-
tively. The greatest margin of error in these experiments,
assuming all myosin molecules contain two acceptors,
would be an underestimation of the distances by 12%.
Within the context of our experiments, this level of error
would not alter our conclusions.
Modeling the FRET distances between the S-2
lysine and three LC2 cysteines
Having confirmed the label specificity reported by Hirat-
suka and his colleagues, we located the MNS probe in space
by reference to the known crystal structure of chicken
skeletal myosin S-1. MNS-labeled lysine was used as a
donor in three separate experiments where acceptor probes
were placed on Cys 109 (from chicken gizzard smooth mus-
cle myosin), Cys125 (from rabbit skeletal fast muscle my-
osin), and Cys 154 (a site-directed mutant of chicken skeletal
fast muscle myosin). The distances were modeled by locat-
ing the probes on the a-carbon backbone of the structure of
Rayment et al. (1993b). Residue 109 from gizzard LC2
corresponds to VallO3 of the chicken skeletal sequence,
based on the sequence alignment of Collins (1991). It would
have been ideal to have known the coordinates of the amino
acid side chains of our labeled residues. These coordinates
for Cys125 and Cys154 were kindly provided by Ivan
Rayment (personal communication), but because the crystal
structure residue corresponding to CyslO9 was a Val, this
side-chain coordinate could not be used.
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FIGURE 4 The left panel illustrates the complete crystal structure of chicken skeletal muscle myosin S-I (a). The myosin heavy chain is shown in green,
LC1 is shown in blue, and LC2 in orange. The panel on the right is a stereo pair view of the light-chain domain of S-1 (only residues 701-843 are
illustrated). The three acceptor labels (at CyslO9, Cysl25, and Cysl54) are superimposed on the LC2 ca-carbon chain. The MNS donor probe is located
at either of the mirror image positions illustrated by the black and grey spheres. The software used for this figure was RasMac version 2.5 ucb and Mage
version 4.2.
Errors that occur because of the length of the amino acid
side chains and the size of the probes themselves may not
necessarily be significant. The distance between the a-car-
bons of Cys125 and Cys154 in the crystal structure is 1.98
nm, whereas the distance reported by us using FRET was
1.97 nm (Boey et al., 1994), i.e., in good agreement for such
a short distance.
Several considerations must be taken into account when
estimating the location of the a-carbon of the MNS-labeled
lysine. The structures of the probes were obtained by energy
minimization using Cerius2 software. 5-IAF has a maximum
cord of 0.95 nm. The maximum cord of the MNS probe was
1.15 nm. We can estimate the position of the MNS-labeled
lysine by a sphere centered at the MNS locus with a diam-
eter of 1.15 nm.
In Fig. 4 b the three a-carbons are colored yellow
(CyslO9), red (Cysl25), and pink (Cysl54), and we as-
sumed that the probes can freely precess around these loci.
The model of the FRET distances shows there are two
possible solutions for the position of the MNS label, the one
indicated by the black sphere and its mirror image (grey
sphere). We calculated the distance from the last residue
identified in the Rayment structure (Lys843) to the black
and grey spheres to be 3.0 and 4.5 nm, respectively. This
result favors the position of the MNS label represented by
the black sphere, because it is closer to the C-terminus of the
MHC.
Allosteric effects of LC2
Miller and Reisler (1985) found that the binding of F-actin
inhibited both the papain and chymotryptic digestion of
HMM at the S1-S2 junction, yielding "long" and "short"
S-1 fragments, respectively. No inhibition occurred when
the HMM contained a degraded (17 or 14 kDa) LC2.
However, when the LC2 was degraded to 18 kDa, digestion
was similar to that obtained in HMM using an intact LC2.
Thus, removal of the first seven N-terminal residues of LC2
has little impact on the chymotryptic susceptibility of the
SI -S2 junction, whereas the removal of a further 11 (or
more) residues renders LC2 incapable of interacting with
this region. The first 18 residues of LC2 are not shown in
the Rayment S-1 structure, because these residues are be-
lieved to be flexible. The data of Miller and Reisler suggest
that the first 18 residues of LC2 "protect" the head-rod
junction cleavage sites in the presence of actin. These data
may be consistent with those of Hiratsuka, who showed that
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the S-2-bound MNS probe becomes "buried" in the pres-
ence of actin. The conformational changes induced by actin
binding that are associated with proteolytic protection and
burial of the MNS probe may be the same. Our FRET data
support this hypothesis by placing the MNS probe close to
the C-terminus of the MHC.
The structural implications of our findings can best be
understood by reference to a stylized cartoon of myosin
structure (Fig. 5). The model of S-1 proposed by Rayment
et al. (1993a) clearly implicates two "hinges" (indicated by
the "screw heads" in this figure). Clear details are provided
for a putative movement of the so-called S-I motor domain
(indicated by the grey arc) relative to the light-chain domain
to which LC1 and LC2 are bound. The three probe loci on
LC2 are shown as black spheres, and the MNS label site is
shown as a white sphere in Fig. 5. Implicit in the model of
Rayment et al. is a second hinge, which enables the light-
chain domain of S-1 to change its attitude (indicated by the
black arc) relative to S-2. Now that we have established a
framework for locating the MNS site, we intend to proceed
to examine the effects of F-actin binding. It remains to be
seen whether this movement can be detected in solution.
..........
S2.
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FIGURE 5 This cartoon depicts the globular motor domain "hinged"
onto the light-chain domain of S-i. The light-chain domain binds both LC1I
(shaded) and LC2 (unshaded), which extends to cover a second "hinge"
(indicated by the screw head) at the junction of S-I and S-2. The three LC2
label loci are shown as black spheres, and the MNS site is drawn as a white
spDhere. The black arc with arrowheads indicates possible movements that
mabdtctd tths ecn "ine b uin heLC-NSloi
CONCLUSION
Based on the Rayment model of S-1, our FRET data are
consistent with the C-terminus continuing in the direction
indicated by these authors. Current theories on the mecha-
nism whereby myosin develops force and is regulated rely
on hinges such as the one adjacent to LC2. Therefore, the
establishment of loci on S-2 and LC2 is an important first
step in detecting movements at this hinge. Experiments are
now in progress to determine whether our MNS-LC FRET
distances are sensitive to the binding of ATP in both the
presence and absence of F-actin.
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